PROK.NASDAQProkidney CORP
Form 4: ProKidney Corp. Director Brian JG Pereira Acquires Stock Options
Sentiment:
SEC Form 4 Filing
Director Brian JG Pereira acquired 62,558 stock options in ProKidney Corp. on May 30, 2024.
Summary
- Brian JG Pereira, a director of ProKidney Corp., acquired 62,558 stock options on May 30, 2024.
- The options were granted under the Issuer's non-employee director compensation policy.
- The exercise price of the options is $4.2.
- The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of the Company's next annual general shareholder meeting.
- The options expire on May 30, 2034.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.
Positives
- The grant of stock options to a director aligns their interests with those of the shareholders.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director can align their interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/30/2024 | Date of the transaction: Brian JG Pereira acquired 62,558 stock options. |
| 05/30/2034 | Expiration date of the stock options. |
| 06/03/2024 | Date of signature of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.